If you see a known complication of a therapy happen in a tiny group of people, that’s pretty concerning. As a cardiologist, I find the constant attempts to minimize the frequency and severity of these adverse events from many quarters really strange.https://twitter.com/zeynep/status/1471166555094405129 …
-
-
Fair, but you’re also not saying boosters for the age group should be halted. You said they shouldn’t be “prioritized” for boosters despite knowing that risk of death/hospitalization from Covid in teens without comorbidities is tiny. Teens with 2 jabs are basically bulletproof.
-
Exactly! That is the problem with current PH guidelines. Unscientific madness.
End of conversation
New conversation -
-
-
“…not saying things like…” why shouldn’t they be said? Why the urge to censor a “public point estimate”? The numbers are taken directly from the trial and the assumptions to get to a NOMINAL 1/39 are clearly laid out and would be familiar to anyone experienced in running them
- Show replies
New conversation -
-
-
If this was any other medical therapy, the conversation with the data to date wouldn’t be about this being a ‘low priority’ group for the therapy.. An IndivualiZed decision of course, but can’t you adequately/reasonably protect granny by boosting her?https://twitter.com/zeynep/status/1471171988093915145 …
-
And boosting the kid with current vax is not going to protect the granny! Omicron infection and spread in boosted clearly shows that! Shocking how they insist not to acknowledge that by now!
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.